Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and efficacy of transitioning uncontrolled glaucoma patients to DuoTrav from other mono or adjunctive therapies.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Cloprostenol; Maleic acid; Ophthalmic Solutions; Timolol; Travoprost

Criteria

Inclusion Criteria:

• Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Age related.

• Other protocol-defined exclusion criteria may apply.